Literature DB >> 9486600

Combined neck dissection and postoperative radiation therapy in the management of the high-risk neck: a matched-pair analysis.

R E Lundahl1, R L Foote, J A Bonner, V J Suman, J E Lewis, J L Kasperbauer, T V McCaffrey, K D Olsen.   

Abstract

PURPOSE: The purpose of this study was to determine the efficacy of postoperative adjuvant radiation therapy with regard to reducing the rate of recurrence in the neck, cancer-related death, and death from any cause in patients with squamous cell carcinoma of the head and neck region metastatic to neck nodes.
METHODS: This was a retrospective review of patients with pathologically confirmed nodal metastases who underwent neck dissection and postoperative adjuvant radiation therapy for squamous cell carcinoma of the head and neck region. Time to recurrence in the dissected area of the neck, any recurrence in the neck, cancer-related death, and death from any cause were estimated with the Kaplan-Meier method. A matched-pair analysis was performed utilizing a cohort of patients who underwent neck dissection without postoperative radiation therapy. The patients from the two cohorts were matched according to previously reported high-risk features for cancer recurrence and death. Cox hazards models for the matched pairs were used to evaluate the relative risk of subsequent recurrence in the dissected side of the neck, any neck recurrence, cancer-related death, and overall survival. MATERIALS: The medical records and pathologic slides of 95 consecutive patients with pathologically confirmed nodal metastases from squamous cell carcinoma of the head and neck region who underwent neck dissection and postoperative adjuvant radiation therapy between January 1974 and December 1990 were reviewed. Previously published data from 284 patients with squamous cell carcinoma of the head and neck region treated with neck dissection alone between January 1970 and December 1980 were used for a matched-pair analysis.
RESULTS: The relative risks for recurrence in the dissected side of the neck, any neck recurrence (dissected neck or delayed undissected neck metastasis), cancer-related death, and death from any cause for patients treated with operation alone relative to those treated with operation and postoperative radiation were 5.82, 4.72, 2.21, and 1.67, respectively.
CONCLUSION: This study provides evidence that postoperative adjuvant radiation therapy for the high-risk neck can reduce the rate of recurrence within a dissected neck, delayed metastasis within an undissected neck, cancer-related death, and death from any cause.

Entities:  

Mesh:

Year:  1998        PMID: 9486600     DOI: 10.1016/s0360-3016(97)00817-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

1.  Effectiveness of postoperative radiotherapy in patients with small oral and oropharyngeal squamous cell carcinoma and concomitant ipsilateral singular cervical lymph node metastasis (pN1) : A meta-analysis.

Authors:  Maximilian Moergel; Philipp Meurer; Katharina Ingel; Thomas G Wendt; Bilal Al-Nawas
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

Review 2.  Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions.

Authors:  Steven B Chinn; Jeffrey N Myers
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

Review 3.  Postoperative radiotherapy for squamous cell carcinoma of the head and neck.

Authors:  William M Mendenhall; Russell W Hinerman; Robert J Amdur; Robert S Malyapa; Christopher D Lansford; John W Werning; Douglas B Villaret
Journal:  Clin Med Res       Date:  2006-09

4.  Chemoradiotherapy is superior to radiotherapy alone after surgery in advanced squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.

Authors:  Jinbiao Shang; Jialei Gu; Qianbo Han; Yaping Xu; Xinmin Yu; Kejin Wang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 5.  The diagnosis and treatment of oral cavity cancer.

Authors:  Klaus-Dietrich Wolff; Markus Follmann; Alexander Nast
Journal:  Dtsch Arztebl Int       Date:  2012-11-30       Impact factor: 5.594

6.  Effectiveness of adjuvant radiotherapy in patients with oropharyngeal and floor of mouth squamous cell carcinoma and concomitant histological verification of singular ipsilateral cervical lymph node metastasis (pN1-state)--a prospective multicenter randomized controlled clinical trial using a comprehensive cohort design.

Authors:  Maximilian Moergel; Antje Jahn-Eimermacher; Frank Krummenauer; Torsten E Reichert; Wilfried Wagner; Thomas G Wendt; Jochen A Werner; Bilal Al-Nawas
Journal:  Trials       Date:  2009-12-23       Impact factor: 2.279

7.  The impact of treatment center on the outcome of patients with laryngeal cancer treated with surgery and radiotherapy.

Authors:  Fadime Can Akman; Nihal Dag; Ozlem Uruk Ataman; Cenk Ecevit; Ahmet Omer Ikiz; Isin Arslan; Sulen Sarioglu; Emel Ada; Munir Kinay
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-04-05       Impact factor: 2.503

8.  Association of Survival With Shorter Time to Radiation Therapy After Surgery for US Patients With Head and Neck Cancer.

Authors:  Jeremy P Harris; Michelle M Chen; Ryan K Orosco; Davud Sirjani; Vasu Divi; Wendy Hara
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-04-01       Impact factor: 6.223

9.  Intraoperative marking of the tumour resection surface for improved radiation therapy planning in head and neck cancer: preclinical evaluation of a novel liquid fiducial marker.

Authors:  David Steybe; Maximilian Frederik Russe; Ute Ludwig; Tanja Sprave; Kirstin Vach; Wiebke Semper-Hogg; Rainer Schmelzeisen; Pit Jacob Voss; Philipp Poxleitner
Journal:  Dentomaxillofac Radiol       Date:  2020-09-11       Impact factor: 2.419

10.  PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors.

Authors:  Alexander Lin; John H C Chang; Ryan S Grover; Frank J P Hoebers; Upendra Parvathaneni; Samir H Patel; Juliette Thariat; David J Thomson; Johannes A Langendijk; Steven J Frank
Journal:  Int J Part Ther       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.